Pary-M Duo Tablet 5/850 mg
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
AhnGuk Pharmaceutical Co., Ltd.
MFDS item code 202201357 · Approved 2022.04.04
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication helps adult patients with type 2 diabetes to manage blood sugar levels more effectively while adhering to diet and exercise. It is especially beneficial for those whose blood sugar is not adequately controlled. It is also used for patients with existing cardiovascular disease, and detailed information regarding its impact on cardiovascular events should be referred to in professional guidelines. Overall, this medication is used to improve blood sugar control and support diabetes management.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each active ingredient: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medicines, such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient’s current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive the same doses of empagliflozin and metformin that they were taking previously. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose of this medicine is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication may cause a rare side effect known as severe lactic acidosis, thus caution is advised particularly in patients with impaired kidney function or heart disease. There is a risk of hypoglycemia when used with other diabetes medications, so blood sugar levels should be monitored frequently and dosages adjusted as necessary. This medication should not be used in patients with moderate to severe renal impairment or conditions that can cause acute kidney injury. Patients scheduled for surgery or receiving radiocontrast agents should discontinue this medication in advance and resume only after kidney function has returned to normal. Pregnant women, those who may become pregnant, and breastfeeding mothers should not take this medication and should consult a healthcare professional for safety. While on this medication, any occurrence of dehydration, severe infection, or acute heart failure warrants immediate consultation with a physician and potentially discontinuation of the medication. The risk of urinary or genital infections may increase, so prompt treatment is necessary if infection symptoms arise. Vitamin B12 levels may decrease, thus regular blood tests to monitor vitamin B12 status are advisable for long-term use. Elderly patients or those with reduced kidney function should have careful consideration regarding dosage and necessity for use, and regular kidney function monitoring is required. Excessive alcohol should be avoided during the use of this medication, as alcohol consumption can increase the risk of lactic acidosis. Hypoglycemic symptoms may occur, and if dizziness, cold sweat, or confusion appears, blood sugar levels should be checked immediately and appropriate measures taken. This medication can cause fluid loss, particularly in patients who are hypotensive or at risk of dehydration; careful observation of fluid status is essential. Routine monitoring of blood sugar, kidney function, liver function, etc., is crucial to detect any adverse signs early during treatment with this medication. Patients taking this medication should be cautious while driving or operating machinery due to the risk of hypoglycemia or dizziness. In the event of overdose, immediate medical attention is required, especially if symptoms of lactic acidosis are suspected.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is recommended to maintain room temperature between 1 to 30 degrees Celsius. Proper storage helps to preserve the effectiveness of the drug for a longer period.
Yellowish-white, bilaterally convex, oval film-coated tablet
10 tablets/box [10 tablets/PTP X 1], 60 tablets/box [10 tablets/PTP X 6], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
AhnGuk Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.